Coral Laboratories share price
You have to be logged in to add this to Watchlist.- ₹488.00(-0.29%)February 12, 2026 15:22:42 PM IST
- NSE
- BSE
- Vol : 0.56 K (NSE + BSE)Last 20 day avg : 2.33 K
Coral Laboratories is trading -0.29% lower at Rs 488.00 as compared to its last closing price. Coral Laboratories has been trading in the price range of 489.40 & 475.00. Coral Laboratories has given 11.61% in this year & 9.87% in the last 5 days. Coral Laboratories has TTM P/E ratio 10.07 as compared to the sector P/E of 23.25.The company posted a net profit of 5.82 Crores in its last quarter.Listed peers of Coral Laboratories include Cipla (-1.50%), Torrent Pharmaceuticals (0.84%), Dr Reddy's Laboratories (0.37%).The Mutual Fund holding in Coral Laboratories was at -% in . The MF holding has - from the last quarter. The FII holding in Coral Laboratories was at 0.23% in 30 Jun 2024. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 12, 2026, 11:08 PM UTC
- BetaHigh volatility1.21Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.02The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.31Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.87The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values10.07Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.26The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Cipla | Bearish | 1,329.55 | -1.50 | 1,07,425.16 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Bullish | 4,091.00 | 0.84 | 1,38,452.47 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Bullish | 1,275.00 | 0.37 | 1,06,763.38 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | Neutral | 6,188.20 | -4.42 | 1,64,277.26 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bullish | 1,712.75 | 0.12 | 4,11,104.64 | 36.24 | 5.77 | 0.92 | 0.50 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-25 | Others |
| 2025-08-13 | Quarterly Results & A.G.M. |
| 2025-05-30 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE683E01017
- BSE Code524506
- NSE Code
Coral Laboratories is trading at 488.00 as on Thu Feb 12 2026 09:52:42. This is -0.29% lower as compared to its previous closing price of 489.40.
The market capitalization of Coral Laboratories is 174.34 Cr as on Thu Feb 12 2026 09:52:42.
The 52 wk high for Coral Laboratories is 850.90 whereas the 52 wk low is 415.00
Coral Laboratories can be analyzed on the following key metrics -
- TTM P/E: 10.07
- Sector P/E: 23.25
- Dividend Yield: 0.31%
- D/E ratio: 0.00
Coral Laboratories reported a net profit of 24.16 Cr in 2025.